Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: A randomized phase II study

Eric Van Cutsem, C. Boni, J. Tabernero, B. Massuti, G. Middleton, F. Dane, P. Reichardt, F. L. Pimentel, A. Cohn, P. Follana, M. Clemens, A. Zaniboni, V. Moiseyenko, M. Harrison, D. A. Richards, H. Prenen, S. Pernot, E. Ecstein-Fraisse, S. Hitier, P. Rougier

Research output: Contribution to journalArticleResearchpeer-review

78 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: A randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences